| Uterine Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived196 of 196show fewer |
|---|
| → investigated in trials for | Cisplatinsmall_molecule 208 trials (54 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 208 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall_molecule 199 trials (66 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 199 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall_molecule 150 trials (55 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 150 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 107 trials (60 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 107 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 87 trials (33 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 87 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall_molecule 51 trials (19 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall_molecule 44 trials (14 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 35 trials (9 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall_molecule 34 trials (5 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 33 trials (6 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall_molecule 29 trials (14 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 28 trials (16 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 27 trials (16 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 26 trials (11 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 22 trials (13 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall_molecule 22 trials (6 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 21 trials (4 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 20 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Megestrolsmall_molecule 19 trials (8 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 18 trials (10 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 17 trials (15 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall_molecule 17 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 16 trials (6 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 16 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 16 trials (4 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 15 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 15 trials (4 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 14 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 14 trials (9 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 14 trials (5 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 13 trials (6 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 12 trials (9 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 12 trials (6 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imiquimodsmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 12 trials (4 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 10 trials (6 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Relugolixsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall_molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leuprolideother 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisotumab Vedotinadc 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lifileucelcell therapy 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mirvetuximab Soravtansineadc 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ridaforolimussmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamoxifensmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trabectedinsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anastrozolesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elacestrantsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall_molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall_molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Datopotamab Deruxtecanadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imlunestrantsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inavolisibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lurbinectedinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemigatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pilaralisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Samotolisibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Therapeutic Tumor Infiltrating Lymphocytes 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tucatinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Uprosertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vistusertibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-VEGF Monoclonal Antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Apitolisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aromatase Inhibitor 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avutometinib And Defactinib 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belzutifansmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bleomycin 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camizestrantsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyproterone Acetatesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dactinomycinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dactolisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Goserelinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hyperthermic Intraperitoneal Chemotherapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Infigratinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lomustinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lunresertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Margetuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Navtemadlinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nedaplatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neratinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nilotinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porcupine Inhibitor WNT974 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prexasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rezatapoptsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rigosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Seribantumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sotorasibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarlatamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taselisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taxol 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Deruxtecanadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vatalanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |